Cervical screening support
Guidance before screening and after Pap smear, HPV or VIA results, including when further review may be needed.
Kebeza helps you choose an appropriate screening pathway, understand an abnormal result and move toward the right follow-up without confusing screening with diagnosis.
Screening aims to find disease before symptoms appear. A new breast lump, persistent bleeding, a growing swelling or another worrying symptom should not be delayed while looking for a general screening package.
Kebeza helps distinguish routine screening from diagnostic assessment and explains which route is appropriate. A recommendation is based on clinical context; one test does not screen for every cancer.
Guidance before screening and after Pap smear, HPV or VIA results, including when further review may be needed.
Help understanding the difference between routine breast screening and assessment of a new lump or imaging concern.
Age, family history, prior results and symptoms can change the appropriate route. Kebeza helps organise a focused discussion instead of promising one universal package.
If screening finds an abnormality, Kebeza can explain the report and help coordinate the next clinical, imaging, sampling or specialist step.
Kebeza's distinction between screening and diagnosis follows established public-health guidance: screening is intended for people without symptoms, while an abnormal finding needs diagnostic follow-up.
No. Kebeza helps identify and coordinate an appropriate pathway. The test and facility depend on age, symptoms, risk and availability, which are confirmed during contact.
A new symptom usually needs clinical assessment rather than routine screening. Kebeza can help organise the next diagnostic step.
Yes. Kebeza can help explain the result and coordinate appropriate follow-up, which may include further examination, imaging, sampling or specialist review.